Viewing nowCombinationAjuStar 80/5 mg
Telmisartan Powder 23.9% 80mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Aju Pharmaceuticals Co., Ltd.

MFDS item code 201605853 · Approved 2016.09.30 · Insurance code 654004800
Treatment of essential hypertension not controlled with monotherapy
This medication is used in patients with essential hypertension who do not have adequate blood pressure control with monotherapy using amlodipine or telmisartan. It effectively lowers blood pressure and helps reduce the risk of cardiovascular complications and maintain health.
The recommended dose is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that the tablet be taken at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components as follows, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended that treatment be initiated at a low dose and the dose increased gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older patients: The usual amlodipine regimen is recommended for older patients, but caution should be exercised when increasing the dose (see section ‘3. Patients Requiring Caution’). Since amlodipine clearance is reduced in patients aged 75 years or older, treatment should be initiated at a low dose and the dose increased gradually.
The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.
This medication should not be used during pregnancy, especially in the second and third trimesters, as it can pose serious risks to the fetus. This drug should not be administered to patients with certain conditions or illnesses such as severe liver dysfunction, heart failure, hypotension, pregnant or breastfeeding women, etc. It should be used with caution in specific patient groups such as those with liver dysfunction, heart valve disease, kidney disease, and the elderly, and requires dosage adjustments and careful monitoring. During the use of this medication, side effects such as dizziness, swelling, and hypotension may occur; if symptoms occur, immediate consultation with healthcare professionals is necessary. Due to the blood pressure-lowering effect, hypotension may occur, so patients with fluid or salt deficiencies should correct or adjust these before starting treatment. As this medication can affect kidney function or potassium levels in the blood, patients with kidney disease should regularly check kidney function and electrolyte status through blood tests. This medication can interact with other medications, so it is essential to inform the doctor or pharmacist of any other medications being taken. If pregnancy is planned or confirmed, immediately discontinue this medication and consult the responsible physician. Breastfeeding women should refrain from taking this medication, and discuss alternative therapeutic options if necessary. This medication is not recommended for children as safety and efficacy have not been established for pediatric patients under 18 years of age. In case of overdose, severe hypotension, dizziness, and cardiac abnormalities may occur, so immediate medical attention is required.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a dark container that prevents light exposure. Additionally, it is important to store the medication at room temperature, i.e., between 1 and 30 degrees Celsius. This storage will help maintain the effectiveness of the medication and ensure safe use.
It is a white and light gray, double-convex, oval-shaped tablet.
30 tablets (10 tablets/PTP X 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 80mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Aju Pharmaceuticals Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.